This Article Full Text Full Text (PDF) Supplemental material Other Versions of this Article: JCM.02259-06v1 45/6/1794    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Woznicová, V. Articles by Valisová, Z. Search for Related Content PubMed PubMed Citation Articles by Woznicová, V. Articles by Valisová, Z.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2007, p. 1794-1797, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.02259-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Performance of CAPTIA SelectSyph-G Enzyme-Linked Immunosorbent Assay in Syphilis Testing of a High-Risk Population: Analysis of Discordant Results ^,

Vladana Woznicová^* and Zuzana Valiová

Department of Medical Microbiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Received 5 November 2006/ Returned for modification 17 January 2007/ Accepted 11 April 2007

Using the Captia Select Syph-G enzyme-linked immunosorbent assay (ELISA), we analyzed the sera of 1,771 patients from a high-risk population attending sexually transmitted disease (STD) clinics. We focused on discrepancies between the results of the immunoglobulin G (IgG) ELISA and the Treponema pallidum hemagglutination (TPHA) test. We identified 57 patients (3.22%) with conflicting results in the IgG ELISA and TPHA test. In order to resolve these discrepancies, these patients’ health records were reviewed and additional serological tests (rapid plasma reagin, IgM ELISA, fluorescent treponemal antibody absorption, and Western blotting) were performed. We subsequently diagnosed 22 of these 57 (38.6%) patients with late latent syphilis. None of the patients with discordant test results was diagnosed with early syphilis. We followed 35 of these 57 patients, analyzing two consecutive serum samples at 3 weeks and at 3 months. Discordant results persisted in 12 (33.3%) patients. We successfully resolved the test result discrepancies for 28 patients (80%) involved in follow-up. Captia SelectSyph-G ELISA showed a sensitivity of 99.0%, a specificity of 98.0%, and positive and negative predictive values of 99.3% and 97.2%, respectively. Based on the results of this study, we conclude that the Captia SelectSyph-G ELISA is a reliable tool for syphilis testing in a high-risk population and recommend the utilization of the Captia SelectSyph-G ELISA as a confirmatory test in at-risk patients.

Published ahead of print on 18 April 2007.

Supplemental material for this article may be found at http://jcm.asm.org/.